Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in ZYME — Zymeworks Inc.

CIK 1692234 Seattle, WA
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,251,240
+$63,095 QoQ
Shares Held
47,867
+0.9% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 202 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. ZYME ranks #109 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in ZYME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,251,240 47,867
2026-03-31 $1,188,145 47,450
2025-12-31 $1,536,352 58,350
2025-09-30 $981,208 57,448
2025-06-30 $355,314 28,312
2025-03-31 $36,361 3,053
2024-12-31 $657,992 44,945
2024-09-30 $624,625 49,771
2024-06-30 $429,761 50,501
2024-03-31 $719,439 68,388
2023-12-31 $280,570 27,004
2023-09-30 $35,117 5,539
2023-06-30 $183,168 21,200
2023-03-31 $44,296 4,900
2022-12-31 $111,171 14,144